Evidence map›Paper›PMID 40202704›Full record

ReviewMolecular neurobiology2025

Potential Roles of Natural Antioxidants in Modulating Neurodegenerative Disease Pathways.

Mega Obukohwo Oyovwi, Ejime A Chijiokwu, Benneth Ben-Azu, Adedeji David Atere, Uchechukwu Gregory Joseph, Udoji Godsday Ogbutor, Onoriode Andrew Udi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mega Obukohwo OyovwiDepartment of Human Physiology, Faculty of Basic Medical Sciences, Delta State University of Science and Technology, Ozoro, Delta State, Nigeria. megalect@gmail.com.
Ejime A ChijiokwuDepartment of Physiology, Delta State University, Abraka, Delta State, Nigeria.
Benneth Ben-AzuDELSU Joint Canada-Israel Neuroscience and Biopsychiatry Laboratory, Department of Pharmacology, Faculty of Basic Medical Sciences, College of Health Sciences, Delta State University, Abraka, Delta State, Nigeria.
Adedeji David AtereDepartment of Medical Laboratory Science, College of Health Sciences, Osun State University, Osogbo, Nigeria.
Uchechukwu Gregory JosephDepartment of Medical Laboratory Science, Faculty of Basic Medical Sciences, Adeleke University, Ede, Osun State, Nigeria.
Udoji Godsday OgbutorDepartment of Physiology, Delta State University, Abraka, Delta State, Nigeria.
Onoriode Andrew UdiDepartment of Human Anatomy, Federal University Otuoke, Yenagoa, Bayelsa State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodegenerative diseases, including Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis, are increasingly prevalent among aging populations. Oxidative stress contributes to these diseases, leading to cellular damage and neuronal death. Natural antioxidants are being explored as preventive measures. This study aims to assess the effectiveness of natural antioxidants in delaying the onset or progression of neurodegenerative diseases by identifying their specific mechanisms of action. A comprehensive review of existing literature was conducted, focusing on studies that examine the role of natural antioxidants in neuroprotection. Key natural antioxidants, including flavonoids, polyphenls, vitamins C and E, and omega-3 fatty acids, were reviewed and analyzed for their bioavailability, mechanisms of action, and outcomes in both in vitro and in vivo studies. Additionally, clinical trials involving human subjects were considered to provide insights into the translational implications of antioxidant consumption. The findings suggest that several natural antioxidants exhibit neuroprotective properties by modulating oxidative stress, reducing inflammation, and promoting neuronal survival. For instance, flavonoids such as quercetin and resveratrol have shown promise in enhancing cognitive function and mitigating the pathophysiological alterations associated with neurodegeneration. In clinical studies, higher intakes of dietary antioxidants were correlated with a reduced risk of developing neurodegenerative disorders. Natural antioxidants offer potential for preventing neurodegenerative diseases by counteracting oxidative stress and maintaining cellular integrity. Overall, our report recommends that further research is needed to optimize dosages and understand their long-term benefits.

Indexed as

AntioxidantsBiological ProductsNeurodegenerative DiseasesSignal TransductionAnimalsHumansNeuroprotective AgentsOxidative StressAntioxidantsBiological ProductsNeuroprotective AgentsAlzheimer’s diseaseAntioxidantsDietary interventionsFlavonoidsInflammationNeurodegenerative diseasesNeuroprotectionOxidative stressParkinson’s diseasePolyphenols

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.